A Baseline Score to Predict Response to Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration

PURPOSE: What are the patient characteristics predictive of response to ranibizumab treatment? METHODS: Model-based characterization of best-corrected visual acuity (BCVA) time profiles of patients with neovascular age-related macular degeneration under ranibizumab or sham treatment based on 24-mont...

Descripción completa

Detalles Bibliográficos
Autores principales: Diack, Cheikh, Schwab, Dietmar, Cosson, Valerie, Buchheit, Vincent, Mazer, Norman, Frey, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114000/
https://www.ncbi.nlm.nih.gov/pubmed/34111259
http://dx.doi.org/10.1167/tvst.10.6.11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114000/
https://www.ncbi.nlm.nih.gov/pubmed/34111259
http://dx.doi.org/10.1167/tvst.10.6.11

Ejemplares similares